Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 24

1.

Comparison of a teratogenic transcriptome-based predictive test based on human embryonic versus inducible pluripotent stem cells.

Shinde V, Perumal Srinivasan S, Henry M, Rotshteyn T, Hescheler J, Rahnenführer J, Grinberg M, Meisig J, Blüthgen N, Waldmann T, Leist M, Hengstler JG, Sachinidis A.

Stem Cell Res Ther. 2016 Dec 30;7(1):190. doi: 10.1186/s13287-016-0449-2.

2.

Do lamotrigine and levetiracetam solve the problem of using sodium valproate in women with epilepsy?

Craig JJ.

Obstet Med. 2012 Mar;5(1):6-13. doi: 10.1258/om.2011.110071. Epub 2012 Feb 20. Review.

3.

Evidence-based guidelines for treating bipolar disorder: Revised third edition recommendations from the British Association for Psychopharmacology.

Goodwin GM, Haddad PM, Ferrier IN, Aronson JK, Barnes T, Cipriani A, Coghill DR, Fazel S, Geddes JR, Grunze H, Holmes EA, Howes O, Hudson S, Hunt N, Jones I, Macmillan IC, McAllister-Williams H, Miklowitz DR, Morriss R, Munafò M, Paton C, Saharkian BJ, Saunders K, Sinclair J, Taylor D, Vieta E, Young AH.

J Psychopharmacol. 2016 Jun;30(6):495-553. doi: 10.1177/0269881116636545. Epub 2016 Mar 15.

4.

Behavioral outcomes in children exposed prenatally to lamotrigine, valproate, or carbamazepine.

Deshmukh U, Adams J, Macklin EA, Dhillon R, McCarthy KD, Dworetzky B, Klein A, Holmes LB.

Neurotoxicol Teratol. 2016 Mar-Apr;54:5-14. doi: 10.1016/j.ntt.2016.01.001. Epub 2016 Jan 12.

5.

Mood stabilizers in pregnancy and lactation.

Grover S, Avasthi A.

Indian J Psychiatry. 2015 Jul;57(Suppl 2):S308-23. doi: 10.4103/0019-5545.161498. Review.

6.

Treatment of bipolar disorders during pregnancy: maternal and fetal safety and challenges.

Epstein RA, Moore KM, Bobo WV.

Drug Healthc Patient Saf. 2014 Dec 24;7:7-29. doi: 10.2147/DHPS.S50556. eCollection 2015. Review.

7.

Alteration of bioelectrically-controlled processes in the embryo: a teratogenic mechanism for anticonvulsants.

Hernández-Díaz S, Levin M.

Reprod Toxicol. 2014 Aug;47:111-4. doi: 10.1016/j.reprotox.2014.04.008. Epub 2014 May 6.

8.

Women and epilepsy.

O'Connor SE, Zupanc ML.

J Pediatr Pharmacol Ther. 2009 Oct;14(4):212-20. doi: 10.5863/1551-6776-14.4.212.

9.

Valproic acid downregulates RBP4 and elicits hypervitaminosis A-teratogenesis--a kinetic analysis on retinol/retinoic acid homeostatic system.

Chuang CM, Chang CH, Wang HE, Chen KC, Peng CC, Hsieh CL, Peng RY.

PLoS One. 2012;7(9):e43692. doi: 10.1371/journal.pone.0043692. Epub 2012 Sep 19.

10.

Use of antiepileptic medications in pregnancy in relation to risks of birth defects.

Werler MM, Ahrens KA, Bosco JL, Mitchell AA, Anderka MT, Gilboa SM, Holmes LB; National Birth Defects Prevention Study.

Ann Epidemiol. 2011 Nov;21(11):842-50. doi: 10.1016/j.annepidem.2011.08.002.

11.

More questions than answers! Clinical dilemmas in psychopharmacology in pregnancy and lactation.

Desai G, Babu GN, Rajkumar RP, Chandra PS.

Indian J Psychiatry. 2009 Jan;51(1):26-33. doi: 10.4103/0019-5545.44901.

12.

Practice parameter update: management issues for women with epilepsy--focus on pregnancy (an evidence-based review): teratogenesis and perinatal outcomes: report of the Quality Standards Subcommittee and Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology and American Epilepsy Society.

Harden CL, Meador KJ, Pennell PB, Hauser WA, Gronseth GS, French JA, Wiebe S, Thurman D, Koppel BS, Kaplan PW, Robinson JN, Hopp J, Ting TY, Gidal B, Hovinga CA, Wilner AN, Vazquez B, Holmes L, Krumholz A, Finnell R, Hirtz D, Le Guen C; American Academy of Neurology; American Epilepsy Society.

Neurology. 2009 Jul 14;73(2):133-41. doi: 10.1212/WNL.0b013e3181a6b312. Epub 2009 Apr 27. Review.

13.

Antiepileptic drugs during pregnancy: what is known and which AEDs seem to be safest?

Pennell PB.

Epilepsia. 2008 Dec;49 Suppl 9:43-55. doi: 10.1111/j.1528-1167.2008.01926.x. Review.

14.

Pregnancy outcomes in women with epilepsy: a systematic review and meta-analysis of published pregnancy registries and cohorts.

Meador K, Reynolds MW, Crean S, Fahrbach K, Probst C.

Epilepsy Res. 2008 Sep;81(1):1-13. doi: 10.1016/j.eplepsyres.2008.04.022. Epub 2008 Jun 18. Review.

15.

Should valproate be taken during pregnancy?

Eadie MJ, Vajda FJ.

Ther Clin Risk Manag. 2005 Mar;1(1):21-6.

16.

Ensuring the safe and effective use of medications during pregnancy: planning and prevention through preconception care.

Cragan JD, Friedman JM, Holmes LB, Uhl K, Green NS, Riley L.

Matern Child Health J. 2006 Sep;10(5 Suppl):S129-35. Epub 2006 Jul 19. Review. No abstract available.

17.

Major malformations with valproic acid.

Koren G, Nava-Ocampo AA, Moretti ME, Sussman R, Nulman I.

Can Fam Physician. 2006 Apr;52:441-2, 444, 447. Review.

18.

Dysmorphic features: an important clue to the diagnosis and severity of fetal anticonvulsant syndromes.

Kini U, Adab N, Vinten J, Fryer A, Clayton-Smith J; Liverpool and Manchester Neurodevelopmental Study Group.

Arch Dis Child Fetal Neonatal Ed. 2006 Mar;91(2):F90-5. Epub 2005 Oct 20.

19.

Malformation risks of antiepileptic drugs in pregnancy: a prospective study from the UK Epilepsy and Pregnancy Register.

Morrow J, Russell A, Guthrie E, Parsons L, Robertson I, Waddell R, Irwin B, McGivern RC, Morrison PJ, Craig J.

J Neurol Neurosurg Psychiatry. 2006 Feb;77(2):193-8. Epub 2005 Sep 12.

20.

Supplemental Content

Support Center